$14.62
00.00%
Pre-Market: 4:02 PM EDT
15 minutes delayed
Inhibrx Biosciences
INBXNASDAQ
Inhibrx Biosciences (INBX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestInhibrx Biosciences (NASDAQ:INBX) Stock Quotes, Forecast and News Summary
Inhibrx Biosciences Stock (NASDAQ: INBX) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 583.01K |
| Day Range | - - - |
| 52 Wk Range | 13.67 - 39.79 |
| Market Cap | $211.64M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 21 |
| Short Interest | 3.89% |
| Days to Cover | 9.61 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Inhibrx Biosciences (INBX) stock?
You can purchase shares of Inhibrx Biosciences (NASDAQ:INBX) through any online brokerage.
Who are Inhibrx Biosciences (INBX) competitors?
Other companies in Inhibrx Biosciences’s space includes: Zura Bio (NASDAQ:ZURA), Tectonic Therapeutic (NASDAQ:TECX), Skye Bioscience (NASDAQ:SKYE), Inovio Pharmaceuticals (NASDAQ:INO) and Adaptimmune Therapeutics (NASDAQ:ADAP).
What is the target price for Inhibrx Biosciences (INBX) stock?
There is no analysis for Inhibrx Biosciences.
What is the forecast for Inhibrx Biosciences (INBX) stock?
Inhibrx Biosciences has a consensus price target of $36.20.
Current stock price for Inhibrx Biosciences (INBX)?
The stock price for Inhibrx Biosciences (NASDAQ: INBX) is $14.62 last updated June 26, 2024 at 4:02 PM EDT.
Does Inhibrx Biosciences (INBX) pay a dividend?
There are no upcoming dividends for Inhibrx Biosciences.
When is Inhibrx Biosciences (NASDAQ:INBX) reporting earnings?
Inhibrx Biosciences’s Q2 earnings are confirmed for Monday, August 5, 2024.
Is Inhibrx Biosciences (INBX) going to split?
There is no upcoming split for Inhibrx Biosciences.
What sector and industry does Inhibrx Biosciences (INBX) operate in?
Inhibrx Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.